N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review
Pediatric oncology is a critical area where the more efficient development of new treatments is urgently needed. The speed of approval of new drugs is still limited by regulatory requirements and a lack of innovative designs appropriate for trials in children. Childhood cancers meet the criteria of...
Guardado en:
Autores principales: | Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e362beda12c3412aac9b32d23e3902c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cost of Oncology Medicines
por: Zlatareva A., et al.
Publicado: (2017) -
Pediatric Oncology Palliative Care Programs in Central America: Pathways to Success
por: Wendy Cristhyna Gómez García, et al.
Publicado: (2021) - Clinical medicine reviews in oncology
-
Precision oncology- the future of personalized cancer medicine?
por: Ann M. Bode, et al.
Publicado: (2017) - European Journal of Oncological Medicine